Sai Life Sciences IPO listing live: Shares of Sai Life Sciences list at ₹650 on NSE, jump 16% higher post listing

2 min read | Updated on December 18, 2024, 11:32 IST

SUMMARY

The ₹3,042 crore public issue of Sai Life Science was oversubscribed 10.27x, and the allotment was finalised on Monday evening. The shares list at an 18.4% premium and jump 7% higher to hit a listing day high of ₹701 per share.

Sai Life Sciences IPO was oversubscribed by 10x with strong participation by retail investors.

Sai Life Sciences IPO listing 10:00 am: Shares price live at 11:10 am

CMP- ₹750

Open-₹650

Low-₹650

High-₹764

Sai Life Sciences IPO listing 10:00 am: Shares jump 4% higher post listing Shares of Sai Life Sciences jumped 4% higher to hit new listing day high of ₹675 per share on the NSE after opening at ₹650 per share on the NSE.

Sai Life Sciences IPO listing 9:52 am: Listing Shares of Sai Life Sciences IPO to list at 18.4% premium on the NSE at ₹650 apiece against the issue price of ₹549 apiece.

Sai Life Sciences IPO listing 9:50 am: Financials Sai Life Sciences reported revenue from operations of ₹1,217.1 crore in FY23, which increased to ₹1,465.1 crore in FY24 and ₹675.29 crore for the first half of FY25. The company’s net profit stood at ₹9.98 crore in FY23, rising significantly to ₹82.80 crore in FY24, with ₹28.01 crore reported in H1FY25.

Sai Life Sciences IPO listing 9:45 am: Objective Sai Life Sciences plans to use the net proceeds from the IPO for specific purposes, which include repayment or prepayment, either in full or part, of its outstanding borrowings. In addition, the company will also use the funds for general corporate purposes.

Sai Life Sciences IPO listing:The mainboard issue was overall subscribed 10.27 times with bids for more than 39.86 crore shares, compared to the 3.88 crore shares on offer.

The qualified institutional buyers (QIBs) showed the highest demand by subscribing their quota 30.93 times, with bids for 33.01 crore shares against the 1.07 crore shares available to them. The non-institutional investors (NIIs) placed bids for 4.15 crore shares against the 84.47 lakh shares on offer, leading to a subscription of 4.92 times in the segment.

The retail segment of the IPO was subscribed 1.3 times as retail investor bid 2.69 crore shares against the offer of 1.97 crore shares.

About The Author

Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL Reg No.: IN-DP-761-2024 | CIN: U65100DL2021PTC376860 | Compliance Officer: Mr. Kapil Jaikalyani. Tel No.: (022) 24229920. Email ID: compliance@upstox.com | Registered Address: 809, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001 | RKSV Commodities India Pvt. Ltd.: SEBI Registration No.: INZ000015837 | MCX TM Code: 46510 | CIN: U74900DL2009PTC189166 | Compliance Officer: Mr. Amit Lalan. Tel No.: (022) 24229920. Email ID: compliance@rksv.in | Registered Address: 807, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001. Correspondence Address: 30th Floor, Sunshine Tower, Senapati Bapat Marg, Dadar (West), Mumbai - 400013. | For any complaints, email at complaints@upstox.com and complaints.mcx@upstox.com.

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES include: Name, PAN, Address, Mobile Number, and E-mail ID. Benefits include effective communication and speedy redressal of grievances. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI, along with our Terms of Use and Privacy Policy.

Upstox Securities Private Limited is a wholly owned subsidiary of RKSV Securities India Private Limited and RKSV Commodities India Private Limited is an associate of RKSV Securities India Private Limited.

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.
*Brokerage will not exceed the SEBI prescribed limit.

Risk disclosures on derivatives -

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Mutual Funds: Top rated funds do not constitute any advice. Research data is powered by Morningstar. Please read the offer documents carefully before investing. Upstox shall not accept any liability arising out of your investments.
These are not Exchange traded products, and the Member is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.

Attention Investors: As per NSE circular dated July 6, 2022, BSE circular dated July 6, 2022, MCX circular dated July 11, 2022 investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. Investors are further cautioned to avoid practices like:
a) Sharing i) trading credentials – login id & passwords including OTP’s., ii) trading strategies, iii) position details.
b) Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c) Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks
d) Dealing in unsolicited tips through like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e) Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.

Kindly, read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets : Advisory Guidelines For Investors

Kindly, read the advisory as prescribed by the Exchange with reference to their circular dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: KYC Updation

Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from CDSL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Upstox or RKSV and offering such services, please send us an email at complaints@upstox.com and complaints.mcx@upstox.com.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. Stockbrokers can accept securities as margin from their clients only by way of a pledge in the depository system w.e.f. 1st September 2020.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number to create a pledge.
Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL/CDSL every month.

Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies. https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the-indian-securities-market_74794.html ODR portal for Investors - https://smartodr.in/login

Sai Life Sciences IPO listing live: Shares of Sai Life Sciences list at ₹650 on NSE, jump 16% higher post listing

Kalpataru Projects International shares slump 3% after raising ₹1,000 crore via QIP

SENSEX down 300 pts, NIFTY50 hovers around 24,250; Va Tech Wabag crashes over 17%

Shares of Sai Life Sciences jump 16% post listing; all you need to know

Ambuja Cements shares in focus as cement major merges subsidiaries, Sanghi and Penna Cement

Trade setup: NIFTY reverses gains: Fed meet impact?

Trade setup: Breakout coming for NIFTY50?